Sherpa Venture Capital

Sherpa Venture Capital, based in Beijing, China, focuses primarily on the healthcare sector, particularly in biotechnology, pharmaceuticals, medical devices, and healthcare services. Since its founding in 2018, Sherpa has grown to be a significant player in the Chinese healthcare investment landscape. Sherpa's portfolio includes notable companies such as BeGene, NovoCodex, Faith Medical, and Innovent Biologics. These companies highlight Sherpa's commitment to advancing medical technology and innovation. The firm typically invests in early to growth-stage companies, providing not just capital but also strategic guidance to help them scale and succeed in the competitive healthcare market​. Sherpa has also made significant co-investments alongside other major venture capital firms like Sequoia Capital China, Lilly Asia Ventures, and Tencent Holdings. This collaborative approach helps leverage a broader network and expertise, facilitating better outcomes for their portfolio companies.